CASP3 and leukemia: Similarly, doxorubicin when used in combination with apigenin synergistically increased caspase 3 activity in three out of four of the leukaemia cell lines (CCRF-CEM, Jurkat and THP-1) (P<0.05), however, this combination only had an additive effect in KG-1a cells (P<0.05).